- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02064270
Study to Compare Negative Pressure Wound Therapy or Standard Dressings After Orthopedic Surgery (PICO)
Prospective Randomized, Controlled Study to Assess Prevention of Incision Healing Complications in Patients Undergoing Total Knee or Hip Arthroplasty, Treated With Either Negative Pressure Wound Therapy or Standard Dressings.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Most surgical wounds heal by primary intention, meaning the wound edges are brought together, or approximated, by some sort of mechanical means (sutures, staples, paper tape, surgical glue or adhesive strips) to heal with minimal scar formation. National clinical guidelines recommend that incisions are covered with a postsurgical cover dressing, for up to a period of 48 hours, to help control postoperative bleeding, absorb exudate, provide mechanical protection, help to reduce edema and provide protection from exogenous sources. Multiple patient comorbidities, environmental factors and the type and length of surgery may elevate certain groups of patients into a higher level of risk of developing a post-surgical complication: calling for a higher degree of vigilance and postsurgical intervention. Surgical complications include; wound dehiscence, infection (deep or superficial), hematomas, seromas, tissue necrosis and delayed incision healing. Complication rates can range from 19% in patients requiring open reduction and internal fixation (ORIF) of tibial plateau, pilon and calcaneus fractures up to 50% in high energy trauma wounds. These complications can have a high degree of morbidity for the patient and further sequelae may result in additional surgical procedures or revisions, a lower functional status for the patient, an increased in length of hospital stay (LOS) and a higher cost for the healthcare provider.
Traditional NPWT has been shown to be an effective adjunct therapy in the treatment of acute and chronic wounds, but the emergence of incisional NPWT (iNPWT) and supporting evidence is growing momentum. In vitro studies have shown that iNPWT may help to improve the stimulation of blood flow, help manage exudate, help to reduce edema, provide a mechanical and "splinting" effect on the incision and provide mechanical protection from the environment. Its impact on the prevention or reduction of post-surgical incision complications is still in its infancy, but recent studies have been encouraging and have demonstrated a statistically significant reduction in infection and dehiscence in patients considered as high-risk following severe skeletal trauma.
The aim of this study is to assess the prevention of incision healing complications in patients undergoing TKA and THA treated with either Single-Use Incisional NPWT compared to standard of care dressings.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65212
- University of Missouri Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- - Patient ≥18 years old
- - Male or non-pregnant females
- - Patient is scheduled to have a surgical procedure for Total Knee Arthroplasty or Total Hip Arthroplasty (Primary or Revision Procedure)
- - The patient is able to understand the trial and is willing to consent to the trial
Exclusion Criteria:
- - Patients who in the opinion of the investigator may not complete the study for any reason
- - Patients with a known history of poor compliance with medical treatment
- - Patients who have participated in this trial previously and who were withdrawn
- - Patients with known allergies to product components (silicone adhesives and polyurethane films (direct contact with wound), acrylic adhesives (direct contact with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within the dressing)
- - Patients not capable of obtaining a standardized digital picture at day 7 (1 week from surgery), and submitting it to the site.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Negative Pressure Wound Therapy
Single-Use Negative Pressure Wound Therapy (NPWT)
|
Application of PICO Single-Use Negative Pressure Wound Therapy
Other Names:
|
|
Active Comparator: Standard dressings
Standard postsurgical dressings
|
Use of Standard postsurgical dressings
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incision Appearance Based on VAS (Incision Healing Assessment Form)
Time Frame: 35 days (+/- 14 days)
|
Visual Analog Pain Scale (VAS): PICO Study Incision Healing Assessment Form.
Used to represent the assessment of incision healing based on in-person visual appearance, or appearance based on standard digital photograph.
This number is reported as a total score on a 0-100 scale, with 0 being poor incision healing and 100 being excellent incision healing.
|
35 days (+/- 14 days)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drainage Amount
Time Frame: 35 days (+/- 14 days)
|
Incision Drainage:
|
35 days (+/- 14 days)
|
|
User-friendliness for Patient
Time Frame: 7 days
|
User-Friendliness of PICO device:
|
7 days
|
|
Number of Participants With Complications
Time Frame: 35 days (+/- 14 days)
|
Complications experienced by the subject within the study period time-frame will be recorded.
|
35 days (+/- 14 days)
|
|
Return to the Operating Room
Time Frame: 35 days (+/- 14 days)
|
Information regarding the subject returning to the operating room within the research study time-frame will be recorded.
|
35 days (+/- 14 days)
|
|
Need for Antibiotics
Time Frame: 35 days (+/- 14 days)
|
The need for additional antibiotics will be recorded.
|
35 days (+/- 14 days)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: James P Stannard, MD, University of Missouri-Columbia
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1208434
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound of Knee
-
Indus Hospital and Health NetworkTerminated
-
Brigham and Women's HospitalWithdrawnWound of Knee | Wound of Skin | Non-melanoma Skin Cancer | Skin Graft Complications | Wound of Lower LegUnited States
-
Germans Trias i Pujol HospitalFundació Institut Germans Trias i PujolUnknownSurgical Wound | Knee DiseaseSpain
-
Johns Hopkins UniversityOrthopaedic Trauma AssociationNot yet recruitingTibial Plateau Fracture | Talus Fracture | Achilles Tendon Repairs/Reconstructions | Calcaneus Fractures | Wound Dehiscence, Surgical | Pilon Fracture of Tibia | Wound Infection Post-Traumatic | Ankle Fracture (Bimalleolar Equivalent, Bimalleolar, or Trimalleolar) | Wound Infection DeepUnited States
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
The Cleveland ClinicCompleted
-
Chandan SenUniversity of Colorado, DenverRecruitingInfections | Wound Infection | Wound Heal | Wound of Skin | Wound Healing DelayedUkraine
-
Brigham and Women's HospitalCompletedSurgical Wound | Wound Heal | Wound of Skin | Wound OpenUnited States
-
University of California, DavisCompletedWound Heal | Wound of SkinUnited States
-
Spectrum Health HospitalsNovadaq Technologies ULC, now a part of StrykerCompletedLower Extremity Amputation | Wound Healing | Below Knee Amputation | Above Knee AmputationUnited States
Clinical Trials on Single-Use Negative Pressure Wound Therapy
-
Smith & Nephew, Inc.Terminated
-
Smith & Nephew, Inc.TerminatedSurgical Incision | Pressure Ulcer | Ulcer Foot | Wound Dehiscence | Ulcer, Leg | Ulcer VenousUnited Kingdom, Germany
-
University of Alabama at BirminghamCompleted
-
University of ArizonaCompletedHigh Risk Pregnancy | Cesarean Wound Disruption With Postnatal ComplicationUnited States
-
ConvaTec Inc.WithdrawnSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound LeakUnited States
-
Sindh Institute of Urology and TransplantationCompletedSurgical Site Infection | Wound Heal | Negative-Pressure Wound Therapy | Stoma Site InfectionPakistan
-
Henry Ford Health SystemWithdrawnSurgical Site Infection | Groin InfectionsUnited States
-
Region SkaneRecruitingPostoperative Complications | Surgical Wound Infection | Skin Cancer | Wound Healing | Bandages | Negative-Pressure Wound Therapy | Skin Grafting | Lower Extremity | Skin Transplantation | Split Thickness Skin Graft | Skin Tumour | LegSweden
-
Murk NiazCompletedSurgical Site Infection | Hepatobiliary Disease | Hepatobiliary DisordersPakistan
-
Zuyderland Medisch CentrumCompletedBreast Cancer | Wound Infection | Wound Complication | Wound Dehiscence | Wound NecrosisNetherlands